Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pietro, Piccolo"'
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 7:149-152
PI-88 is a potent antiproliferative agent, which is developed for various indications in cancer. This agent is obtained from yeast fermentation and is primarily composed of pentamannose and tetramannose oligosacchafide units. PI-88 is capable of prca
Autor:
Jawed Fareed, Debra Hoppensteadt, Christopher Schultz, Robert J. Linhardt, Omer Iqbal, Sarfraz Ahmad, Muzaffer Demir, Pietro Piccolo
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 7:131-140
Heparinomimetic mannopentaose phosphate sulfate (PI-88) (Progen Industries Ltd. Brisbane, Australia), currently developed as an anticoagulant and antiproliferative agent, mainly is composed of a pentomannan. However, tetrasaccharide and disaccharide
Autor:
Carlo, Cernetti, Bernhard, Reimers, Amedeo, Picciolo, Salvatore, Saccà, Giampaolo, Pasquetto, Pietro, Piccolo, Luca, Favero, Andrea, Bonanome, Ivano, Dell'Olivo, Pietro, Pascotto
Publikováno v:
Italian heart journal : official journal of the Italian Federation of Cardiology. 4(10)
Carotid artery stenting is emerging as an alternative to surgical endarterectomy for the treatment of extracranial carotid artery disease. However, few data are available on the long-term clinical efficacy of carotid artery stenting and on the incide